Irvine drug developer Spectrum Pharmaceuticals Inc.’s stock is on the rise as it looks to new uses for its flagship drug and takes a step toward biotechnology. Spectrum, which has annual sales of ...

rvine drug developer Spectrum Pharmaceuticals Inc. topped Wall Street projections with fourth-quarter results released earlier this month. The cancer drug maker earned $4.4 million in the quarter, ...

CHICAGO – Spectrum Brands Inc. (SPC) said on Monday that federal prosecutors are investigating recent disclosures by the consumer products company regarding earnings and financial forecasts, sending ...

NEW YORK (AP) -- Spectrum Pharmaceuticals Inc. said Wednesday it will buy Talon Therapeutics Inc. for as much as $206 million, gaining Talon's leukemia drug Marqibo. Spectrum will pay $11.3 million ...